We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Transformed cell-derived reactive oxygen species support and inhibit nitric oxide-mediated apoptosis induction.
International Journal of Oncology 2002 July
Nitric oxide has been recently shown to require interaction with extracellular superoxide anions and subsequent peroxynitrite formation for selective apoptosis induction in transformed fibroblasts. In addition to foster NO-mediated apoptosis, transformed target cell-derived reactive oxygen species (ROS) also exhibit a marked inhibitory effect directed against NO-mediated apoptosis. This inhibition can be abrogated by catalase and can be augmented by hydrogen peroxide generation through glucose oxidase. Therefore, transformed fibroblasts at high density seem to inhibit NO-mediated apoptosis through hydrogen peroxide formation. Inhibition of NO-mediated apoptosis can be explained by the interaction of hydrogen peroxide with NO, resulting in the generation of hydroxyl radicals. As hydrogen peroxide as well as NO represent far ranging species, hydroxyl radical generation occurs more likely distant from the cell membrane and therefore does not have an apoptosis-inducing effect on the cells. In total, this reaction is rather blunting apoptosis induction mediated by NO. The interaction of hydrogen peroxide with NO may have consequences for the control of transformed cells by NO-utilizing natural antitumor systems.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app